NVCR Q1 2018 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q1 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$52M+49.4% YoY

Gross Profit

$34M65.0% margin

Operating Income

-$13M-24.3% margin

Net Income

-$21M-39.8% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

-2.9%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$19M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$303M

Total Liabilities

$197M

Stockholders' Equity

$106M

Cash & Equivalents

$112M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$35M	+49.4%
Gross Profit	$34M	$23M	+46.0%
Operating Income	-$13M	-$13M	+5.2%
Net Income	-$21M	-$18M	-14.8%

Geographic Segments

UNITED STATES

$38M73%

E M E A

$14M27%

JAPAN

$449,0001%